CAMBRIDGE, Mass., Feb. 27, 2017 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting at the Cowenand Company 37th Annual Healthcare Conference on Monday, March 6, 2017, at 4:00 p.m. ET in Boston, MA. A live webcast of Infinity's presentation will
About InfinityInfinity is an innovative biopharmaceutical company dedicated to advancing novel medicines for people with cancer. Infinity is advancing IPI-549, an oral immuno-oncology development candidate that selectively inhibits PI3K-gamma. A Phase 1 study in patients with advanced solid tumors is ongoing. For more information on Infinity, please refer to Infinity's website at www.infi.com.
Contact:Jaren Irene Madden, Senior Director, Investor Relations and Corporate Communications617-453-1336 or Jaren.Madden@infi.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/infinity-to-present-at-37th-annual-cowen-and-company-healthcare-conference-300413327.html
SOURCE Infinity Pharmaceuticals, Inc.
Subscribe to our Free Newsletters!
Learn the basics about diabetes and how to bring it under control with turmeric, an highly ...
Antioxidants are artificial or natural components that help protect the human body from the damage ...
Angiogenesis is the process of formation of new blood vessels from pre-existing blood vessels. It ...View All